{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T22:31:58Z","timestamp":1770417118900,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Renal hyperparathyroidism is a disease entity that is complex and poorly understood. Although there are guidelines regarding how to manage this patient group, evidence is scarce. Therefore, this survey-based study aims to map the physicians\u2019 attitude in terms of preference for management of renal hyperparathyroidism and the influence of patient and respondent factors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A survey was sent to Dutch societies of nephrology, endocrinology, and surgeons with interest in endocrine surgery. The survey consisted of eight case vignettes of renal hyperparathyroidism patients who were on hemodialysis and suitable for kidney transplantation, and varied in one of three patient variables import for decision making: age (40 vs. 65\u2009years), parathyroid hormone (40 vs. 90\u2009pmol\/L), and serum calcium level (2.25 vs. 2.8\u2009mmol\/L). For each case, respondents could choose between maintaining conservative treatment (active vitamin D metabolites), calcimimetics, or subtotal parathyroidectomy as their treatment of choice. Categorical multilevel logistic models were used to investigate the association of patient and respondent variables with treatment preference. The influence of patient variables was determined independently of each other and by means of logistic regression the probabilities of treatment choice were calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 115 surveys were included in the analysis. In 6 out of 8 cases, less than two-thirds of respondents agreed on the most favoured treatment. Among patient characteristics, the main disincentive for respondents not to choose conservative therapy was an elevated serum calcium level (subtotal parathyroidectomy vs conservative OR 93.1, 95%-CI: 48.39\u2013179.07 and calcimimetics vs conservative OR 31.2 95%-CI: 18.58\u201352.30). Additionally, the most significant treatment differences were found between medical specialties and the experience of the respondents, expressed as the amount of cases the physician was involved in during the past year.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Elevated serum calcium levels were widely recognized and the prime reason for respondents to abandon conservative treatment. However, considerable disagreement in treatment preferences remained throughout the cases, demonstrating the current literature available being inconclusive in guiding physicians. Therefore, a high-quality trial comparing subtotal parathyroidectomy to medical treatment is needed to determine optimal treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-021-02361-7","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T15:02:46Z","timestamp":1619190166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Practice variation in the treatment of patients with renal hyperparathyroidism: a survey-based study in the Netherlands"],"prefix":"10.1186","volume":"22","author":[{"given":"Jaimie L. H.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha M.","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard L.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris I.","family":"Rotmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abbey","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"2361_CR1","doi-asserted-by":"publisher","first-page":"184321","DOI":"10.1155\/2015\/184321","volume":"2015","author":"E Hedgeman","year":"2015","unstructured":"Hedgeman E, Lipworth L, Lowe K, Saran R, Do T, Fryzek J. International burden of chronic kidney disease and secondary hyperparathyroidism: a systematic review of the literature and available data. Int J Nephrol. 2015;2015:184321.","journal-title":"Int J Nephrol"},{"issue":"4","key":"2361_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1457496919866015","volume":"109","author":"WY van der Plas","year":"2020","unstructured":"van der Plas WY, Noltes ME, van Ginhoven TM, Kruijff S. Secondary and tertiary hyperparathyroidism: a narrative review. Scand J Surg. 2020;109(4):271\u20138. https:\/\/doi.org\/10.1177\/1457496919866015.","journal-title":"Scand J Surg"},{"issue":"5","key":"2361_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.suc.2009.06.011","volume":"89","author":"SC Pitt","year":"2009","unstructured":"Pitt SC, Sippel RS, Chen H. Secondary and tertiary hyperparathyroidism, state of the art surgical management. Surg Clin North Am. 2009;89(5):1227\u201339. https:\/\/doi.org\/10.1016\/j.suc.2009.06.011.","journal-title":"Surg Clin North Am"},{"issue":"4","key":"2361_CR4","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ecl.2017.07.008","volume":"46","author":"L Zand","year":"2017","unstructured":"Zand L, Kumar R. The use of vitamin D metabolites and analogues in the treatment of chronic kidney disease. Endocrinol Metab Clin N Am. 2017;46(4):983\u20131007. https:\/\/doi.org\/10.1016\/j.ecl.2017.07.008.","journal-title":"Endocrinol Metab Clin N Am"},{"key":"2361_CR5","doi-asserted-by":"publisher","unstructured":"Komaba H, Nakanishi S, Fujimori A, Tanaka M, Shin J, Shibuya K, et al. Cinacalcet effectively reduces parathyroid hormone secretion and gland volume regardless of pretreatment gland size in patients with secondary hyperparathyroidism. Clin J Am Soc Nephrol. 2010;5(12):2305\u201314. https:\/\/doi.org\/10.2215\/CJN.02110310.","DOI":"10.2215\/CJN.02110310"},{"issue":"4","key":"2361_CR6","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/ki.2014.349","volume":"87","author":"GJ Behets","year":"2015","unstructured":"Behets GJ, Spasovski G, Sterling LR, Goodman WG, Spiegel DM, De Broe ME, et al. Bone histomorphometry before and after long-term treatment with cinacalcet in dialysis patients with secondary hyperparathyroidism. Kidney Int. 2015;87(4):846\u201356. https:\/\/doi.org\/10.1038\/ki.2014.349.","journal-title":"Kidney Int"},{"key":"2361_CR7","doi-asserted-by":"publisher","unstructured":"Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, et al. Effect of Etelcalcetide vs Cinacalcet on serum parathyroid hormone in patients receiving hemodialysis with secondary hyperparathyroidism: a randomized clinical trial. Jama. 2017;317(2):156\u201364. https:\/\/doi.org\/10.1001\/jama.2016.19468.","DOI":"10.1001\/jama.2016.19468"},{"key":"2361_CR8","doi-asserted-by":"publisher","unstructured":"Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, et al. Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study. Clin J Am Soc Nephrol. 2015;10(1):98\u2013109. https:\/\/doi.org\/10.2215\/CJN.12941213.","DOI":"10.2215\/CJN.12941213"},{"issue":"7","key":"2361_CR9","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2215\/CJN.10370915","volume":"11","author":"SM Kim","year":"2016","unstructured":"Kim SM, Long J, Montez-Rath ME, Leonard MB, Norton JA, Chertow GM. Rates and outcomes of Parathyroidectomy for secondary hyperparathyroidism in the United States. Clin J Am Soc Nephrol. 2016;11(7):1260\u20137. https:\/\/doi.org\/10.2215\/CJN.10370915.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2361_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"KDIGO","year":"2017","unstructured":"KDIGO. Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl (2011). 2017;7(1):1\u201359.","journal-title":"Kidney Int Suppl (2011)"},{"issue":"1","key":"2361_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.5334\/irsp.90","volume":"30","author":"N Sommet","year":"2017","unstructured":"Sommet N, Morselli D. Keep calm and learn multilevel logistic modeling: a simplified three-step procedure using Stata, R, Mplus, and SPSS. Int Rev Soc Psychol. 2017;30(1):203\u201318. https:\/\/doi.org\/10.5334\/irsp.90.","journal-title":"Int Rev Soc Psychol"},{"key":"2361_CR12","doi-asserted-by":"publisher","unstructured":"Kestenbaum B, Andress DL, Schwartz SM, Gillen DL, Seliger SL, Jadav PR, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004;66(5):2010\u20136. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00972.x.","DOI":"10.1111\/j.1523-1755.2004.00972.x"},{"key":"2361_CR13","doi-asserted-by":"publisher","unstructured":"Sharma J, Raggi P, Kutner N, Bailey J, Zhang R, Huang Y, et al. Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg. 2012;214(4):400\u20137; discussion 7-8. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2011.12.046.","DOI":"10.1016\/j.jamcollsurg.2011.12.046"},{"issue":"8","key":"2361_CR14","doi-asserted-by":"publisher","first-page":"e68870","DOI":"10.1371\/journal.pone.0068870","volume":"8","author":"PT Goldenstein","year":"2013","unstructured":"Goldenstein PT, Elias RM, Pires de Freitas do Carmo L, Coelho FO, Magalh\u00e3es LP, Antunes GL, et al. Parathyroidectomy improves survival in patients with severe hyperparathyroidism: a comparative study. PLoS One. 2013;8(8):e68870.","journal-title":"PLoS One"},{"key":"2361_CR15","doi-asserted-by":"publisher","unstructured":"Ivarsson KM, Akaberi S, Isaksson E, Reihn\u00e9r E, Rylance R, Pr\u00fctz KG, et al. The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant. 2015;30(12):2027\u201333. https:\/\/doi.org\/10.1093\/ndt\/gfv334.","DOI":"10.1093\/ndt\/gfv334"},{"issue":"2","key":"2361_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/ki.2015.72","volume":"88","author":"H Komaba","year":"2015","unstructured":"Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M. Parathyroidectomy and survival among Japanese hemodialysis patients with secondary hyperparathyroidism. Kidney Int. 2015;88(2):350\u20139. https:\/\/doi.org\/10.1038\/ki.2015.72.","journal-title":"Kidney Int"},{"key":"2361_CR17","doi-asserted-by":"publisher","unstructured":"Narayan R, Perkins RM, Berbano EP, Yuan CM, Neff RT, Sawyers ES, et al. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis. 2007;49(6):801\u201313. https:\/\/doi.org\/10.1053\/j.ajkd.2007.03.009.","DOI":"10.1053\/j.ajkd.2007.03.009"},{"issue":"8","key":"2361_CR18","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00423-015-1344-5","volume":"400","author":"K Lorenz","year":"2015","unstructured":"Lorenz K, Bartsch DK, Sancho JJ, Guigard S, Triponez F. Surgical management of secondary hyperparathyroidism in chronic kidney disease--a consensus report of the European Society of Endocrine Surgeons. Langenbeck's Arch Surg. 2015;400(8):907\u201327. https:\/\/doi.org\/10.1007\/s00423-015-1344-5.","journal-title":"Langenbeck's Arch Surg"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02361-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02361-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02361-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T15:03:52Z","timestamp":1619190232000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02361-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2361"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02361-7","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For this kind of general evaluation of routine care no ethical approval is required by law within the Netherlands. As announced in the survey, aggregated data was anonymous and used for the analyses done in this manuscript. Therefore, participating meant consent to these terms.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}